title: Lung cavities in Sjögren's syndrome.
authors.affiliation: Department of Pulmonary and Critical Care, Mayo Clinic, Rochester, MN, USA srivali.narat@mayo.edu.
authors.forename: N
authors.initials: N
authors.lastname: Srivali
authors.affiliation: Department of Rheumatology, Mayo Clinic, Rochester, MN, USA.
authors.forename: P
authors.initials: P
authors.lastname: Ungprasert
authors.affiliation: Department of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
authors.forename: W
authors.initials: W
authors.lastname: Cheungpasitporn
authors.affiliation: Department of Internal Medicine, Bassett Medical Center, Cooperstown, NY, USA.
authors.forename: C
authors.initials: C
authors.lastname: Thongprayoon
authors.affiliation: Department of Pulmonary and Critical Care, Mayo Clinic, Rochester, MN, USA.
authors.forename: S M
authors.initials: SM
authors.lastname: Caples
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001706:Biopsy / Q000379:methods; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008168:Lung / Q000473:pathology*; D017563:Lung Diseases, Interstitial / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage*; D012859:Sjogren's Syndrome / Q000150:complications*; D014057:Tomography, X-Ray Computed / Q000379:methods; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D011241:Prednisone